6533b7d9fe1ef96bd126c278

RESEARCH PRODUCT

Sex-Specific Differences in the Control of Serum Concentrations of Glycine in Subjects with Metabolic Syndrome and Mendelian Randomization Analysis for Obesity

Rocío BarragánDolores CorellaOscar ColtellJose M. OrdovasJosé V. SorlíEva M. AsensioEva C. Pascual

subject

Nutrition and Dieteticsbusiness.industryMedicine (miscellaneous)PhysiologySingle-nucleotide polymorphismGenome-wide association studyMendelian Randomization Analysismedicine.diseaseObesityDiabetes mellitusNutrient-Gene InteractionsGlycinemedicineAlleleMetabolic syndromebusinessFood Science

description

OBJECTIVES: Glycine is a novel circulating marker for metabolic diseases associated with lower type-2 diabetes and protection against obesity in some studies. Circulating glycine levels are genetically determined under the control of several loci. The locus most strongly associated is the carbamoyl-phosphate synthase I (CPS1). Interestingly, some sex-specific genome-wide association studies (GWAS) showed differences in the effect of the main single nucleotide polymorphisms (SNPs) in this locus on glycine levels (significant sex * CPS1 interactions). However, the potential mechanisms explaining this sex-heterogeneity are unknown. Therefore, our aims were: 1) to analyze whether the sex * CPS1 interaction for serum glycine is present in subjects from a Mediterranean population, and 2) to test, in another population, the glycine sex-specific associations with obesity, using a Mendelian randomization approach. METHODS: We studied 426 subjects (aged 55–75 y) with metabolic syndrome from the PREDIMED Plus-Valencia Study. Serum glycine was determined by NMR spectroscopy. We screened the CPS1 gene for SNP associations. In another Mediterranean population (PREDIMED-Valencia participants, n = 1009) we analyzed the sex-specific associations between the genetically determined glycine (CPS1-SNP) and obesity, using Mendelian randomization. RESULTS: In the PREDIMED Plus-Valencia subjects, serum glycine levels were higher in women than in men (280 vs 240 micromol/L, respectively; P = 1.4 × 1E15). The CPS1-rs7684 (3’-UTR) SNPs was strongly associated with glycine levels in women but not in men (P for sex * CPS1 interaction = 0.004), replicating previous findings. The minor allele was associated with lower serum glycine. In the Mendelian randomization study in the population with unmeasured glycine levels, the CPS1-rs7684 SNPs presented a sex-specific interaction for obesity (P < 0.05). Women with the minor allele (lower glycine levels) were more likely to be obese than homozygous women for the major allele (P < 0.05). No associations were detected in men. CONCLUSIONS: We replicated the sex * CPS1 interaction in determining glycine levels and also detected sex * CPS1 interactions for obesity risk. FUNDING SOURCES: Generalitat Valenciana (PROMETEO2017/017, APOSTD/2019/136), Fundació La Marató de TV3 (538/U/2016), and CIBEROBN.

10.1093/cdn/nzaa058_001https://europepmc.org/articles/PMC7258170/